Hong Kong stocks of Huajian Medical rose another 9% during the session, with a cumulative increase of over 200% in the past four weeks

ChainCatcher news, Hong Kong listed company Huajian Medical (01931.HK) rose another 9% during the trading session, with a cumulative increase of over 200% in the past four weeks. As of the time of writing, it is up 7.3%, priced at HKD 6.17, with a trading volume of HKD 23.3243 million.

According to previous news from ChainCatcher, Huajian Medical announced at the end of July that it had signed a strategic cooperation framework agreement with BGI CoWin to jointly establish the Huajian-BGI CoWin innovative drug intellectual property tokenization fund (IVD-BGI CoWin).